LAURUSLABS:NSE
Laurus Labs Ltd
2 075,60 INR
arrow_upward
+0,75%(+15,50) 1 d.
19. 10., 10:12:16 GMT+5:30 · INR
search
Všetky symboly
| Symbol | Cena | Zmena | % zmeny |
|---|
insights_autoGenerujú sa najdôležitejšie štatistiky pre LAURUSLABS…
Otvoriť
2 060,10 INR
Vysoká
2 089,00 INR
Nízka
2 052,20 INR
Trh. kap.
1,12 bil.
Priem. obj.
1,60 mil.
Objem
328,51 tis.
Dividenda
0,10 %
Štvrťročná dividenda
0,50 INR
Prvý obchodný deň po vyplatení dividendy
8. 5. 2026
Pomer cena/zárobky
102,62
Max. za 52 týž.
2 089,00 INR
Min. za 52 týž.
901,40 INR
Výnosy na akciu
20,23 INR
Akcie v obehu
106,44 mil.
Počet zamestnancov
7 tis.
Otvoriť
2 060,10 INR
Vysoká
2 089,00 INR
Nízka
2 052,20 INR
Trh. kap.
1,12 bil.
Priem. obj.
1,60 mil.
Objem
328,51 tis.
Dividenda
0,10 %
Štvrťročná dividenda
0,50 INR
Prvý obchodný deň po vyplatení dividendy
8. 5. 2026
Pomer cena/zárobky
102,62
Max. za 52 týž.
2 089,00 INR
Min. za 52 týž.
901,40 INR
Výnosy na akciu
20,23 INR
Akcie v obehu
106,44 mil.
Počet zamestnancov
7 tis.
Spravodajstvo
Z internetových zdrojov a od spravodajských partnerov
The New York Times
·
pred 42 minútami
On This Day, Oct. 19: In 1987, the stock market crashed.
Stocktwits
·
pred 26 minútami
No ‘Black Monday’? Nasdaq, S&P 500, Dow Futures Spike As Big Tech Earnings Loom This Week — Retail Stays Cautious
BigGo Finance
·
pred 37 minútami
South Korea's FSS Chief Says Solidigm's Nasdaq Listing Would Constitute Duplicate Listing, Hints at Conveying Concerns to SK Hynix
Bloomberg.com
·
pred 6 hodinami
US Stock Futures Rise Ahead of Busy Earnings Week: Markets Wrap
Profil
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava.
Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
Informácie o subjekte Laurus Labs Ltd
Generálny riaditeľSatyanarayana Chava
Zamestnanci7,06 tis.
Dátum založenia2005
Hlavné sídlo-
Odvetvie-